These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 7530293)
21. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats. Lorrain DS; Matuszewich L; Hull EM Brain Res; 1998 Apr; 790(1-2):217-23. PubMed ID: 9593901 [TBL] [Abstract][Full Text] [Related]
22. Effects of the 5-HT(1A) agonist (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on cocaine choice in cynomolgus monkeys. Czoty PW; McCabe C; Nader MA Behav Pharmacol; 2005 May; 16(3):187-91. PubMed ID: 15864074 [TBL] [Abstract][Full Text] [Related]
23. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Marsden CA; Martin KF Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656 [TBL] [Abstract][Full Text] [Related]
25. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex. Kuroki T; Ichikawa J; Dai J; Meltzer HY Brain Res; 1996 Dec; 743(1-2):357-61. PubMed ID: 9017269 [TBL] [Abstract][Full Text] [Related]
26. Differences in the effects of 5-HT(1A) receptor agonists on forced swimming behavior and brain 5-HT metabolism between low and high aggressive mice. Veenema AH; Cremers TI; Jongsma ME; Steenbergen PJ; de Boer SF; Koolhaas JM Psychopharmacology (Berl); 2005 Mar; 178(2-3):151-60. PubMed ID: 15448978 [TBL] [Abstract][Full Text] [Related]
27. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia. Kline AE; Massucci JL; Dixon CE; Zafonte RD; Bolinger BD J Neurotrauma; 2004 Feb; 21(2):175-85. PubMed ID: 15000758 [TBL] [Abstract][Full Text] [Related]
28. 8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol. Carey R; Damianopoulos E; De Palma G Pharmacol Biochem Behav; 2000 Aug; 66(4):863-72. PubMed ID: 10973527 [TBL] [Abstract][Full Text] [Related]
29. Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT. McBlane JW; Handley SL Psychopharmacology (Berl); 1994 Oct; 116(2):173-82. PubMed ID: 7532313 [TBL] [Abstract][Full Text] [Related]
30. Central 5-HT1A receptors inhibit adrenocortical secretion. Welch JE; Farrar GE; Dunn AJ; Saphier D Neuroendocrinology; 1993; 57(2):272-81. PubMed ID: 8510803 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Yu H; Lewander T Eur Neuropsychopharmacol; 1997 Aug; 7(3):165-72. PubMed ID: 9213074 [TBL] [Abstract][Full Text] [Related]
32. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin. Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561 [TBL] [Abstract][Full Text] [Related]
33. The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus. Nomikos GG; Arborelius L; Svensson TH Eur J Pharmacol; 1992 Jun; 216(3):373-8. PubMed ID: 1425929 [TBL] [Abstract][Full Text] [Related]
34. Neurochemical effects of 8-hydroxy-2-di-n-propylamino tetralin in rats treated with haloperidol. Shireen E; Qurrat-ul-Ain ; Batool F; Saify ZS; Haleem DJ Pak J Pharm Sci; 2002 Jan; 15(1):71-82. PubMed ID: 16414870 [TBL] [Abstract][Full Text] [Related]
36. Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT. Levy AD; Li Q; Van de Kar LD Neuropharmacology; 1994; 33(3-4):335-42. PubMed ID: 7984271 [TBL] [Abstract][Full Text] [Related]
37. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. Meller E; Li H; Carr KD; Hiller JM J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306 [TBL] [Abstract][Full Text] [Related]
38. A nitric oxide synthase inhibitor reduces hyperphagia induced in rats by the 5-HT(1A) receptor agonist, 8-OH-DPAT, independently of hypothalamic serotonin metabolism. Yamada J; Sugimoto Y; Kunitomo M Eur J Pharmacol; 2000 Aug; 402(3):247-50. PubMed ID: 10958891 [TBL] [Abstract][Full Text] [Related]
39. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain. Casanovas JM; Vilaró MT; Mengod G; Artigas F J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078 [TBL] [Abstract][Full Text] [Related]
40. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]